By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Catalyst Pharmaceutical Partners, Inc. 

355 Alhambra Circle, Suite 1500

Coral Gables  Florida  33134  U.S.A.
Phone: 305-529-2522 Fax: 305-529-0933



Company News
Catalyst Pharma (CPRX) Announces Agreement With FDA On Confirmatory Phase III Study Protocol For Firdapse In Lambert-Eaton Myasthenic Syndrome 6/13/2016 7:53:34 AM
Catalyst Pharma (CPRX) To Present At The Jefferies 2016 Healthcare Conference 6/1/2016 8:19:18 AM
Catalyst Pharma (CPRX)’s Firdapse Phase III Study Published In Muscle & Nerve 5/18/2016 7:54:05 AM
Catalyst Pharma (CPRX) Axes 30% of Workforce to Conserve Cash 5/17/2016 6:09:43 AM
Catalyst Pharmaceuticals (CPRX) Announces First Quarter 2016 Financial Results And Provides Corporate Update 5/11/2016 9:00:52 AM
Catalyst Pharmaceuticals (CPRX) Must Run Another Study of Its Firdapse Drug: FDA 4/26/2016 7:16:27 AM
Catalyst Pharmaceuticals (CPRX) Announces Fourth Quarter And Year-End 2015 Financial Results 3/16/2016 8:19:34 AM
Catalyst Pharmaceuticals (CPRX)To Present At The 28th Annual ROTH Conference 3/10/2016 1:54:17 PM
Catalyst Pharmaceuticals (CPRX) To Hold Fourth Quarter Financial Results Conference Call And Webcast On Wednesday, March 16th, 2016 3/9/2016 8:06:03 AM
Catalyst Pharmaceuticals (CPRX) Appoints Brian Elsbernd As Senior Vice President Of Legal And Compliance 2/26/2016 7:58:11 AM